Immunology of Cell Death in Cancer Immunotherapy
Over the last two decades, a large volume of studies has established that dying and dead cancer cells exert a potent immunomodulatory effect on their immediate microenvironment, which has a major influence on the anticancer immunity [...]
Main Authors: | Lorenzo Galluzzi, Abhishek D. Garg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1208 |
Similar Items
-
The role of biomarkers in personalized immunotherapy
by: Kamya Sankar, et al.
Published: (2022-05-01) -
Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach
by: Gillian Murtagh, et al.
Published: (2024-02-01) -
Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy
by: Frankie Chi Fat Ko, et al.
Published: (2023-05-01) -
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials
by: Jeffrey R. Whiteaker, et al.
Published: (2023-05-01) -
The Immunotherapy Landscape in Adrenocortical Cancer
by: Guillaume J. Pegna, et al.
Published: (2021-05-01)